Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by Health referenced a June 2019 contributor piece published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The contributor article, titled “The Deadly Costs of Insulin,” noted the significant price increases of insulin treatment, from $14 for 1 vial in 2001 to $275 in 2019.
A piece by Patheos spotlighted an article published on AJMC.com, titled “Mental Health Issues On the Rise Among Adolescents, Young Adults.” The article details rates of mood disorders and suicide-related outcomes that have increased significantly among adolescents and young adults, with a possible link to the rise of social media.
An article by Herald-Tribune cited a study published in the January 2021 issue of AJMC® titled “Differences in the Use of Telephone and Video Telemedicine Visits During the COVID-19 Pandemic.” The study found lower use of video vs telephone visits among older, Black, Hispanic, and Spanish-speaking patients amid the COVID-19 pandemic, driven largely by clinician and practice factors.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More